FY2024 (April 1, 2023 - March 31, 2024)

(Millions of Yen)
Takara Holdings
Inc.
(Consolidated)
y-o-
y(%)
Takara
Shuzo
y-o-
y(%)
Takara
Shuzo
International
Group
y-o-
y(%)
Takara
Bio
Group
y-o-
y(%)
Sales to customer 339,372 96.8% 123,786 100.7% 160,427 116.7% 43,505 55.7%
Cost of sales 225,438 97.7% 92,057 98.3% 108,711 114.3% 16,597 49.7%
Gross profit 113,933 95.0% 31,728 108.4% 51,715 122.0% 26,908 60.1%
SG&A expenses 91,691 111.8% 26,225 107.5% 39,423 124.9% 23,905 98.7%
Operating income 22,242 58.6% 5,503 112.5% 12,291 113.6% 3,003 14.6%
Non-operating
income
2,161 128.8% 388 71.3% 483 153.0% 513 141.5%
Non-operating
expenses
1,066 116.2% 256 45.1% 715 421.9% 111 50.3%
Ordinary income 23,336 60.3% 5,635 115.8% 12,059 110.0% 3,405 16.5%
Extraordinary gain 4,034 240.0% 23 36.7% 42 498.1% 3 0.4%
Extraordinary loss 1,132 162.9% 510 217.3% 65 96.1% 554 142.7%
Income before
income taxes and
minority interests
26,238 66.1% 5,148 109.6% 12,036 110.3% 2,853 13.4%
Net income
attributable to
owners of the parent
16,176 76.3% 3,554 109.8% 7,451 115.8% 1,480 9.2%
―――― ―――― ―――― ―――― ―――― ―――― ―――― ―――― ――――
Research and
development
expenses
8,725 97.5% 391 106.4% 0 - 8,324 97.1%
Capital
expenditures
21,915 154.7% 4,108 148.6% 6,624 140.8% 10,960 168.2%
Depreciation 9,999 109.7% 2,586 104.8% 2,618 128.2% 4,279 105.7%
Amortization of
goodwill
1179 118.1% 0 - 539 135.1% 640 106.9%